2015 American Transplant Congress
Murine Veno-Arterial Extracorporeal Membrane Oxygenation (mVA-ECMO): A Novel Tool to Study the Molecular Biology of Mechanical Circulatory Support
PURPOSE: In recent years, clinical use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has grown. Extracorporeal circulation is an essential component of heart and lung transplantation,…2015 American Transplant Congress
Assessment of Bleeding and Thrombosis in Responders and Initial Non-Responders to Aspirin After Continuous-Flow Left Ventricular Assist Device Placement
Medical University of South Carolina, Charleston, SC.
Purpose: This study evaluates bleeding and thrombosis following left ventricular assist device (LVAD) placement using platelet inhibition monitoring to determine responders to standard aspirin dosing…2015 American Transplant Congress
Non-Cardiac Surgical Procedures After Left Ventricular Assist Device Implantation
Introduction: As left ventricular assist devices (LVAD) are increasingly used for patients with end-stage heart failure, the need for non-cardiac surgical procedures (NCS) in these…2015 American Transplant Congress
The Impact of Perioperative Bleeding on Long-Term Outcomes of Mechanical Circulatory Support
1Sentara Norfolk General Hospital, Norfolk, VA; 2Eastern Virginia Medical School, Norfolk, VA.
Purpose: Postoperative bleeding is a common complication of MCS surgery. The incidence of bleeding in published series exceeds by several times the 3-5% rates seen…2015 American Transplant Congress
Increased Frequency of Terminally Differentiated and Exhausted CD8+ T Cells Is Associated With Adverse Clinical Outcome After Mechanical Circulatory Support Device Implantation
Clinical outcomes vary after mechanical circulatory support device (MCSD) implantation, with some patients developing multi organ system dysfunction (MOD), sometimes leading to death. We hypothesized…